Homepage / Certification of Suitability / News and General Information

Certification of Suitability to the Monographs of the European Pharmacopoeia: News & General Information

Certification Monthly Report of Activities

(16/01/12) The Certification of Substances Division (DCEP) will publish on a monthly basis, a report containing some relevant figures relating to its main activities. December 2011 Certification Monthly Report

Events

International Conference on the Certification Procedure "1992-2012: 20 Years of Experience", 22-23 March 2012, Larnaca, Cyprus

CEP Suspensions:

Following inspection of the manufacturing site(s):

 

Date Substance name CEP Number
20/12/11 Azathioprine CEP 2001-341
20/12/11 Ticlopidine Hydrochloride CEP 2003-066
20/12/11 Haloperidol CEP 2003-206
20/12/11 Risperidone CEP 2004-135
20/12/11 Diphenoxylate Hydrochloride CEP 2005-084
20/12/11 Nifuroxazide CEP 2006-074

04/11/11

Isosorbide mononitrate, diluted

CEP 2002-104

04/11/11

Protamine sulfate

CEP 2000-162

06/10/11 Oxytetracycline Dihydrate CEP 2002-211
06/10/11 Oxytetracycline Hydrochloride CEP 2002-070
06/10/11 Oxytetracycline Hydrochloride CEP 2001-125

 

Due to a failure to comply with a declaration of willingness to be inspected and/or to operate according to EU GMP (e.g. refusal, of inspection, reconstruction/restoration of site(s), to achieve GMP level, and temporary closure):

 

 

Date Substance name CEP Number

20/12/11

Troxerutin

CEP 2006-153

15/09/11

Theophylline

CEP 1998-094

 

Upon request from the holder, due to a temporary inability to produce the API under the approved conditions

 

Date Substance name CEP Number
   None  

 

 

CEP Withdrawals:
As a result of an inspection of the manufacturing site(s):

 

Date Substance name CEP Number

15/09/11

Paclitaxel

CEP 2008-005

 

Due to a failure to fulfill the requirements of the CEP procedure with regards to updating the application and complying with GMP:

 

Date Substance name CEP Number

12/09/11

Tiamulin hydrogen fumarate for veterinary use

CEP 2007-008

12/09/11

Ribavirin

CEP 2009-257

 

Additional Information & Documentation

List of all assessors (Updated 18/10/11)

 

EDQM Policy ‘Suspension or Cancellation of a Certificate of Suitability' PA/PH/CEP (08) 17, R2

retour page précédente

retour haut de page

7 allée Kastner, CS 30026, F67081 Strasbourg, France - Tel. +33 (0)3 88 41 30 30 - Fax +33 (0)3 88 41 27 71
Created by 2exVia with MasterEdit®